# Integra Lifesciences Holdings Corp: filings

IART · Nasdaq · CIK 917520 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iart.md) · [Financials](/companies/iart/financials.md) · [Filings](/companies/iart/filings.md) · [Insiders](/companies/iart/insiders.md)

## Reports and events: 381 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 856, 8-K 273, SC 13G/A 86, 10-Q 54, 3 36, DEF 14A 19, 10-K 18, SC 13G 13, SD 13, 8-K/A 10, S-8 9, ARS 8, S-3ASR 5, SC 13D/A 5, SCHEDULE 13G/A 5, UPLOAD 4, 144 3, 424B2 3, 424B5 3, CORRESP 3, DEFA14A 3, SCHEDULE 13G 3, 4/A 2, 5 2, CT ORDER 2, PRE 14A 2, SC TO-C 2, 10-Q/A 1, NT 10-K 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:01 ET | [10-Q](/filings/0000917520-26-000077.md) | Quarterly report, period 2026-09-30 | 0000917520-26-000077 |
| 2026-10-21 | 10:15 ET | [8-K](/filings/0000917520-26-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000073 |
| 2026-10-19 | 20:20 ET | [8-K](/filings/0001193125-26-425271.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-425271 |
| 2026-10-09 | 21:26 ET | [8-K](/filings/0001193125-26-419228.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-419228 |
| 2026-10-02 | 12:20 ET | [8-K](/filings/0000917520-26-000067.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-26-000067 |
| 2026-09-08 | 10:30 ET | [8-K](/filings/0000917520-26-000061.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-26-000061 |
| 2026-07-29 | 20:03 ET | [10-Q](/filings/0000917520-26-000058.md) | Quarterly report, period 2026-06-30 | 0000917520-26-000058 |
| 2026-07-29 | 10:15 ET | [8-K](/filings/0000917520-26-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000055 |
| 2026-05-08 | 20:15 ET | [8-K](/filings/0000917520-26-000044.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000917520-26-000044 |
| 2026-05-05 | 20:03 ET | [10-Q](/filings/0000917520-26-000041.md) | Quarterly report, period 2026-03-31 | 0000917520-26-000041 |
| 2026-05-05 | 10:20 ET | [8-K](/filings/0000917520-26-000034.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-26-000034 |
| 2026-05-05 | 10:15 ET | [8-K](/filings/0000917520-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000033 |
| 2026-04-15 | 20:24 ET | [8-K](/filings/0000917520-26-000019.md) | 1.01 Entry into a material agreement | 0000917520-26-000019 |
| 2026-04-06 | 20:43 ET | [DEF 14A](/filings/0000917520-26-000015.md) | Proxy statement, period 2025-12-31 | 0000917520-26-000015 |
| 2026-02-26 | 21:02 ET | [10-K](/filings/0000917520-26-000011.md) | Annual report, period 2025-12-31 | 0000917520-26-000011 |
| 2026-02-26 | 11:15 ET | [8-K](/filings/0000917520-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-26-000008 |
| 2025-12-12 | 21:31 ET | [8-K](/filings/0000917520-25-000100.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-25-000100 |
| 2025-10-30 | 20:05 ET | [10-Q](/filings/0000917520-25-000096.md) | Quarterly report, period 2025-09-30 | 0000917520-25-000096 |
| 2025-10-30 | 10:15 ET | [8-K](/filings/0000917520-25-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000094 |
| 2025-07-31 | 20:02 ET | [10-Q](/filings/0000917520-25-000074.md) | Quarterly report, period 2025-06-30 | 0000917520-25-000074 |
| 2025-07-31 | 10:15 ET | [8-K](/filings/0000917520-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000069 |
| 2025-06-09 | 10:30 ET | [8-K](/filings/0000917520-25-000060.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000917520-25-000060 |
| 2025-05-13 | 20:45 ET | [8-K](/filings/0000917520-25-000052.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000917520-25-000052 |
| 2025-05-05 | 20:07 ET | [10-Q](/filings/0000917520-25-000041.md) | Quarterly report, period 2025-03-31 | 0000917520-25-000041 |
| 2025-05-05 | 10:45 ET | [8-K](/filings/0000917520-25-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000038 |
| 2025-04-04 | 20:43 ET | [DEF 14A](/filings/0000917520-25-000032.md) | Proxy statement, period 2024-12-31 | 0000917520-25-000032 |
| 2025-02-25 | 22:06 ET | [10-K](/filings/0000917520-25-000017.md) | Annual report, period 2024-12-31 | 0000917520-25-000017 |
| 2025-02-25 | 11:15 ET | [8-K](/filings/0000917520-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-25-000014 |
| 2025-01-06 | 13:00 ET | [8-K](/filings/0000917520-25-000004.md) | 8.01 Other events | 0000917520-25-000004 |
| 2024-12-17 | 21:15 ET | [8-K](/filings/0000917520-24-000121.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-24-000121 |
| 2024-11-04 | 21:09 ET | [10-Q](/filings/0000917520-24-000108.md) | Quarterly report, period 2024-09-30 | 0000917520-24-000108 |
| 2024-11-04 | 11:20 ET | [8-K](/filings/0000917520-24-000106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000106 |
| 2024-11-04 | 11:15 ET | [8-K](/filings/0000917520-24-000105.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-24-000105 |
| 2024-07-29 | 20:07 ET | [10-Q](/filings/0000917520-24-000094.md) | Quarterly report, period 2024-06-30 | 0000917520-24-000094 |
| 2024-07-29 | 10:15 ET | [8-K](/filings/0000917520-24-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000092 |
| 2024-05-17 | 00:09 ET | [8-K](/filings/0000917520-24-000074.md) | 8.01 Other events | 0000917520-24-000074 |
| 2024-05-13 | 20:38 ET | [8-K](/filings/0000917520-24-000066.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000917520-24-000066 |
| 2024-05-06 | 20:09 ET | [10-Q](/filings/0000917520-24-000061.md) | Quarterly report, period 2024-03-31 | 0000917520-24-000061 |
| 2024-05-06 | 10:15 ET | [8-K](/filings/0000917520-24-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000059 |
| 2024-04-04 | 20:39 ET | [DEF 14A](/filings/0000917520-24-000053.md) | Proxy statement, period 2023-12-31 | 0000917520-24-000053 |
| 2024-02-28 | 21:13 ET | [10-K](/filings/0000917520-24-000022.md) | Annual report, period 2023-12-31 | 0000917520-24-000022 |
| 2024-02-28 | 11:15 ET | [8-K](/filings/0000917520-24-000018.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-24-000018 |
| 2024-02-28 | 11:10 ET | [8-K](/filings/0000917520-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-24-000017 |
| 2024-02-27 | 22:15 ET | [8-K/A](/filings/0000917520-24-000011.md) | 5.02 Departure or appointment of officers or directors | 0000917520-24-000011 |
| 2023-12-20 | 21:57 ET | [8-K](/filings/0000917520-23-000082.md) | 1.01 Entry into a material agreement | 0000917520-23-000082 |
| 2023-12-13 | 21:31 ET | [8-K](/filings/0000917520-23-000079.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000917520-23-000079 |
| 2023-12-13 | 11:30 ET | [8-K](/filings/0000917520-23-000077.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000917520-23-000077 |
| 2023-10-25 | 20:21 ET | [10-Q](/filings/0000917520-23-000071.md) | Quarterly report, period 2023-09-30 | 0000917520-23-000071 |
| 2023-10-25 | 10:15 ET | [8-K](/filings/0000917520-23-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000917520-23-000069 |
| 2023-08-16 | 01:15 ET | [8-K](/filings/0000917520-23-000065.md) | 8.01 Other events | 0000917520-23-000065 |

Page 1 of 8. [Older](/companies/iart/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.